Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Aten Primaria ; 36(3): 129-34, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-16029741

RESUMO

OBJECTIVE: To analyse pharmacist intervention (PI) resulting from the implementation of the Dáder Pharmacotherapeutic Follow-Up Program (PFU). DESIGN: Descriptive study of the findings from the PFU program during the first year. SETTING: Community pharmacists in area of the College of Pharmacists of the Province of Cordoba (Argentina). PARTICIPANTS: A total of 202 patients were included in the PFU, selected on the basis of the observed needs by each of the participating pharmacists. PRINCIPAL MEASUREMENTS: From the resulting PI reports the sex and age were obtained and problems related to medication (PRM) were classified according to the Second Consensus of Granada. The method of resolving PRM, the number of medications used and the number of visits made to the pharmacy to resolve each of them. RESULTS: 38 pharmacists participated and 108 patients were registered in the PI. The number of PI increased to 280, with 218 PRM resolved (77.9% effectiveness: 95% confidence interval [CI], 70.6-86.2). 25% of the PRM were resoled between the pharmacist and the patient and 75% required the participation of the doctor, the PI achieving an acceptance of 74.6% (95% CI, 67.8-82.6). CONCLUSIONS: A high percentage of resolving PRM was obtained, with a significant acceptance of the PI by the doctors, which demonstrates the feasibility of including community pharmacists in the medical team and the possibility that they could make a significant contribution in decreasing the mobility and mortality associated with medications by carrying out PFU activities.


Assuntos
Serviços Comunitários de Farmácia/estatística & dados numéricos , Prescrições de Medicamentos/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Serviços Comunitários de Farmácia/economia , Custos e Análise de Custo , Prescrições de Medicamentos/economia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Farmácia/estatística & dados numéricos
2.
RNC ; 10(1): 5-16, ene.-mar. 2001. tab
Artigo em Espanhol | LILACS | ID: lil-330728

RESUMO

En el presente trabajo se propone un modelo de evaluación fármaco-económico del tipo de análisis costo-efectividad con el objeto de mejorar el procedimiento de la selección de alternativas asociadas a la elaboración y empleo de Nutrición Parenteral (NP) en la Unidad de Cuidados Intensivos (UCI) de un Servicio de Neonatología. Los costos se valoran en unidades monetarias y los beneficios en unidades naturales de efectividad. Se realizó un estudio prospectivo de febrero a septiembre de 1997, de los pacientes internados en la UCI de un Servicio de Neonatología que requerían NP. Dicho servicio pertenece a un hospital público de la ciudad de Córdoba. Se establecieron las alternativas de comparación: 1- Preparación y utilización de mezclas de NP en la misma Institución, independiente del Servicio de Farmacia (SF). 2- Preparación y utilización de mezclas de NP en la misma Institución, tras la implementación de una unidad de NP dependiente del SF. 3- Tercerizar la elaboración de NP...


Assuntos
Humanos , Recém-Nascido , Análise Custo-Eficiência , Nutrição Parenteral/economia , Preparações Farmacêuticas/economia , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA